Journal of Materials Chemistry B,
Journal Year:
2024,
Volume and Issue:
12(11), P. 2795 - 2806
Published: Jan. 1, 2024
Oxidative
stress
and
reactive
oxygen
species
drive
ischemic
stroke
its
related
complications.
New
antioxidant
medications
are
therefore
crucial
for
treating
stroke.
We
developed
Ti2C@BSA-ISO
nanocomposites
loaded
with
the
hydrophobic
drug
isoquercetin
(ISO)
encapsulated
in
BSA
on
Ti2C
nano-enzymes
as
a
novel
therapeutic
nanomedicine
treatment
of
targeting
(ROS).
TEM
visually
proved
successful
preparation
Ti2C@BSA-ISO,
FTIR,
XPS,
zeta
potential
DLS
together
demonstrated
acquisition
Ti2C@BSA-ISO.
In
addition,
enzyme-mimicking
activity
was
evaluated
capacity
verified.
able
to
reverse
decrease
cellular
caused
by
ROS.
Experiments
vivo
showed
that
could
promote
neuroprotection
scavenging
ROS
hippocampal
CA1
area
cerebral
cortex
rats,
thereby
inhibiting
death
alleviating
ischaemic
Specifically,
alleviated
NLRP3/caspase-1/GSDMD
pathway-mediated
pyroptosis.
Our
study
demonstrates
effectiveness
nanomedicines
can
be
directly
used
drugs
synergy
other
drugs,
which
greatly
expands
application
nanomaterials
ACS Biomaterials Science & Engineering,
Journal Year:
2024,
Volume and Issue:
10(4), P. 1892 - 1909
Published: March 11, 2024
MXenes
and
their
composites
hold
great
promise
in
the
field
of
soft
bone
tissue
regeneration
engineering
(TRE).
However,
there
are
challenges
that
need
to
be
overcome,
such
as
ensuring
biocompatibility
controlling
morphologies
MXene-based
scaffolds.
The
future
prospects
TRE
include
enhancing
through
surface
modifications,
developing
multifunctional
constructs,
conducting
vivo
studies
for
clinical
translation.
purpose
this
perspective
about
is
critically
evaluate
potential
applications
contributions
field.
This
aims
provide
a
comprehensive
analysis
challenges,
advantages,
limitations,
associated
with
use
TRE.
By
examining
existing
literature
research,
review
seeks
consolidate
current
knowledge
highlight
key
findings
advancements
It
contribute
understanding
MXenes'
role
promoting
TRE,
addressing
faced
terms
biocompatibility,
morphology
control,
interactions.
Materials,
Journal Year:
2024,
Volume and Issue:
17(6), P. 1423 - 1423
Published: March 20, 2024
MXenes
are
two-dimensional
transition
metal
carbides,
nitrides,
and
carbonitrides
that
have
become
important
materials
in
nanotechnology
because
of
their
remarkable
mechanical,
electrical,
thermal
characteristics.
This
review
emphasizes
how
crucial
MXene
conjugates
for
several
biomedical
applications,
especially
the
field
cancer.
These
(2D)
nanoconjugates
with
photothermal,
chemotherapeutic,
photodynamic
activities
demonstrated
promise
highly
effective
noninvasive
anticancer
therapy.
conjugates,
distinctive
optical
capabilities,
been
employed
bioimaging
biosensing,
excellent
light-to-heat
conversion
efficiency
makes
them
perfect
biocompatible
notably
proficient
nanoscale
agents
photothermal
applications.
The
synthesis
characterization
provide
a
framework
an
in-depth
understanding
various
fabrication
techniques
importance
customized
formation
conjugates.
following
sections
explore
MXene-based
nanotheranostics
demonstrate
enormous
potential
Nanoconjugates,
such
as
polymers,
metals,
graphene,
hydrogels,
biomimetics,
quantum
dots,
radio
exhibit
unique
properties
can
be
used
therapeutic
diagnostic
applications
cancer
nanotheranostics.
An
additional
layer
into
safety
concerns
is
provided
by
detailing
toxicity
viewpoints.
Furthermore,
concludes
addressing
opportunities
challenges
clinical
translation
nanoconjugates,
emphasizing
real-world
medical
practices.
Journal of Materials Chemistry B,
Journal Year:
2024,
Volume and Issue:
12(11), P. 2795 - 2806
Published: Jan. 1, 2024
Oxidative
stress
and
reactive
oxygen
species
drive
ischemic
stroke
its
related
complications.
New
antioxidant
medications
are
therefore
crucial
for
treating
stroke.
We
developed
Ti2C@BSA-ISO
nanocomposites
loaded
with
the
hydrophobic
drug
isoquercetin
(ISO)
encapsulated
in
BSA
on
Ti2C
nano-enzymes
as
a
novel
therapeutic
nanomedicine
treatment
of
targeting
(ROS).
TEM
visually
proved
successful
preparation
Ti2C@BSA-ISO,
FTIR,
XPS,
zeta
potential
DLS
together
demonstrated
acquisition
Ti2C@BSA-ISO.
In
addition,
enzyme-mimicking
activity
was
evaluated
capacity
verified.
able
to
reverse
decrease
cellular
caused
by
ROS.
Experiments
vivo
showed
that
could
promote
neuroprotection
scavenging
ROS
hippocampal
CA1
area
cerebral
cortex
rats,
thereby
inhibiting
death
alleviating
ischaemic
Specifically,
alleviated
NLRP3/caspase-1/GSDMD
pathway-mediated
pyroptosis.
Our
study
demonstrates
effectiveness
nanomedicines
can
be
directly
used
drugs
synergy
other
drugs,
which
greatly
expands
application
nanomaterials